Award
NIH Reporter #3U01NS110772-05S3
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Recipient
University of Cincinnati, Neurology
Award Amount
$50,000.00
Ceiling
$50,000.00
Awarded
March 05, 2026
Identifier
3U01NS110772-05S3
The NIH-funded FASTEST Trial evaluates whether administering recombinant Factor VIIa within two hours of spontaneous intracerebral hemorrhage improves 90-day functional outcomes compared with placebo.
Description
A randomized, double-blind, controlled global trial testing recombinant Factor VIIa plus best standard therapy versus best standard therapy alone for patients with intracerebral hemorrhage.